Allergan PLC is the latest firm targeted by the US Department of Justice in its investigation of price hikes in the generic drug industry.
The company reported in its Aug
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?